Skip to content
Arctic TherapeuticsArctic Therapeutics
Uncategorized

Nacuity Pharmaceuticals and Arctic Therapeutics Enter Licensing Agreement and Strategic Partnership to Develop NPI-001

Posted on 21.02.202330.05.2023 by admin
21
Feb

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

This entry was posted in Uncategorized. Bookmark the permalink.
admin

Arctic Therapeutics has been awarded, by Life Sciences Review, as the top genomics solutions provider in Europe/UK 2022

Leave a Reply Cancel reply

You must be logged in to post a comment.

Recent Posts

  • Arctic Therapeutics awarded a highly prestigious multi-million grant from the EIC Accelerator
  • Arctic Therapeutics’ founder and CMO, Hákon Hákonarson, ranked among the top 2% of scientists in the world
  • Arctic Therapeutics has been awarded, by Life Sciences Review, as the top genomics solutions provider in Europe/UK 2022
  • Nacuity Pharmaceuticals and Arctic Therapeutics Enter Licensing Agreement and Strategic Partnership to Develop NPI-001

Recent Comments

No comments to show.

arctic therapeutics logo

image showing that arctic therapeutics is accredited with accrediation number 10530

Arctic Therapeutics is accredited for
Molecular Biology and Clinical Virology.

Copyright © 2023 - Arctic Therapeutics - Legal disclaimer - Privacy policy - info@arctictherapeutics.com

Copyright 2023 ©
  • Company
    Pipeline
    AT-001
    Approach
    Team
    Media
    Contact